ArticleScience China. Life sciences2026
MdRAD5B regulates the chromatin accessibility of MdMYB14 under cold by associating with a transcription factor MdLSD1.
Article in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RADIATION SENSITIVE 5B (MdRAD5B) has previously been identified as a chromatin remodeler involved in regulating the chromatin accessibility and H3K27me3 modification of genes. However, how RAD5B regulates the chromatin accessibility of target genes remains largely unclear. Here, we find that MdRAD5B positively regulates apple cold tolerance by modulating the expression of cold-responsive genes. Under cold stress, MdRAD5B regulates the expression of cold-responsive genes, including MdMYB14, through its chromatin remodeling function. Further study reveals that the transcription factor LESION SIMULATING DISEASE 1 (MdLSD1) recruits MdRAD5B and reduces the chromatin accessibility of MdMYB14. MdMYB14, a downstream target of MdLSD1 and a negative regulator of cold tolerance, binds to the promoter region of MdCBF3 and inhibits its expression. Additionally, we identified a natural variation, a non-synonymous mutation at position 1,780 of the RAD5B CDS (RAD5B
Indexed as
Identifiers
42909749What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.